Clinical Trial Update: Chronic Treatment With Benfotiamine Restores Endothelial Function in People With Type 2 Diabetes Mellitus [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update reports that chronic treatment with benfotiamine restores endothelial function in people with Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Benfotiamine (benfotiamine)

Snippet

Sponsor: Ruhr University of Bochum | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: UNKNOWN